JP Morgan Maintains Overweight on Abbott Laboratories, Raises Price Target to $120

Benzinga · 1d ago
JP Morgan analyst Robbie Marcus maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $110 to $120.